Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative S-1/CDDP in Stage III Gastric Cancer
NCT00182611Phase 3Completed
- Sponsor
- Kyoto University
- Start
- Apr 2004
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gastric cancer (GC) comparing Control (Surgery + Adjuvant S-1) with Neoadjuvant S-1/Cisplatin + Surgery + Adjuvant S-1 (2 arms). Primary endpoint: Overall survival. Started Apr 2004; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00182611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182611.